Saturn V Capital Management LLC Cytokinetics Inc Transaction History
Saturn V Capital Management LLC
- $255 Billion
- Q4 2024
A detailed history of Saturn V Capital Management LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Saturn V Capital Management LLC holds 348,364 shares of CYTK stock, worth $12.8 Million. This represents 6.42% of its overall portfolio holdings.
Number of Shares
348,364
Previous 331,283
5.16%
Holding current value
$12.8 Million
Previous $17.5 Billion
6.32%
% of portfolio
6.42%
Previous 6.25%
Shares
9 transactions
Others Institutions Holding CYTK
# of Institutions
404Shares Held
116MCall Options Held
3.46MPut Options Held
1.86M-
Black Rock Inc. New York, NY14.7MShares$538 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$437 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.8MShares$394 Million0.31% of portfolio
-
State Street Corp Boston, MA6.17MShares$226 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA2.84MShares$104 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $3.45B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...